Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 19.0%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large drop in short interest in November. As of November 30th, there was short interest totalling 154,200 shares, a drop of 19.0% from the November 15th total of 190,400 shares. Based on an average daily volume of 35,200 shares, the short-interest ratio is currently 4.4 days.

CNBX Pharmaceuticals Price Performance

OTCMKTS CNBX remained flat at $0.01 on Friday. 90 shares of the company were exchanged, compared to its average volume of 181,553. CNBX Pharmaceuticals has a 52 week low of $0.01 and a 52 week high of $0.02. The business has a fifty day moving average of $0.01 and a 200 day moving average of $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc, a clinical stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome.